Logo image

Parkinson's disease treatment with gene-targeting therapy

Parkinson's disease treatment with gene-targeting therapy
1
Media Files
1

Overview

Type of care

Outpatient

Method

Non-surgical

About the offer

Gene-targeting therapy is a cutting-edge treatment approach that uses genetic engineering to target specific genes or proteins involved in a disease. For example, in the case of Parkinson's disease, gene-targeting therapies aim to address the cause of the condition - the loss of dopamine-producing neurons. These therapies can improve motor symptoms, slow disease progression, and enhance the patient's quality of life. A suitable gene-targeting therapy is chosen based on the patient's needs and disease progression. Options include GAD (increasing GABA), AADC (boosting dopamine production), GDNF (protecting brain cells), and TH-GCH-AADC (triple gene therapy for balancing brain chemicals and enhancing dopamine production). Depending on the type, the selected gene therapy is prepared and administered through a surgical procedure or injection. This process involves introducing the therapeutic genes into the patient's brain cells, where they work to address the targeted issue. After the treatment, patients are closely monitored to assess their response to the therapy and identify potential side effects. It may involve regular medical check-ups, neurological assessments, and imaging studies. Gene-targeting therapy for Parkinson's may be used as a standalone treatment or combined with existing therapies like medications and deep brain stimulation (DBS). In addition, gene treatment can be tailored to patients' needs, enhancing treatment effectiveness.

What’s included

Medical service

Examination
  • clinical history-taking
  • medical records review
  • physical examination
  • consultation with a neurologist
Laboratory tests
  • complete blood count (CBC)
  • inflammation blood tests
Diagnosis
  • neurological examination
  • Levodopa test
  • MRI scan of the brain
Treatment
  • pre-procedure patient preparation
  • gene-targeting therapy for Parkinson's disease: 
    • Glutamic acid decarboxylase (GAD)
    • Aromatic amino acid decarboxylase (AADC)
    • Glial-derived neurotrophic factor (GDNF)
    • Tyrosine hydroxylase, Guanosine triphosphate cyclohydrolase, and Aromatic amino acid decarboxylase (TH-GCH-AADC)
  • post-procedure care
  • symptomatic treatment
Other
  • cost of essential medicines
  • cost of essential materials
  • nursing service
  • discharge medical records
  • further recommendations

AiroCare

AiroMedical support
Payment protection
Patient advocacy
Price match

Customize this offer

If you're not seeing exactly what you need here, send your custom request. You can discuss the content, specifics, price & timeline to create a personalized plan.

FAQ

How long does the offer take?

The offer is designed for 14 days.

Does the offer require you to stay in the clinic overnight?

Where can I see the media files?

What are the age restrictions?

The offer is eligible for both adults and kids.

Can I customize the content of the offer?

Yes, the components of the deal can be changed. Get in touch with a vendor to create a personalized proposal.

Individual cost estimate. Non-binding 100% free assessment.

Similar deals